未登录.png)
分享.png)
收藏分享 收藏 分享 收藏 Efficacy and Safety of CT-P43, a Candidate Ustekinumab Biosimilar, in Moderate-to-Severe Plaque Psoriasis: 52-Week Results From a Randomised, Active-Controlled, Double-Blind, Phase III StudyCT-P43（一种乌司木单抗生物类似药候选药物）在斑块状银屑病（中度至重度）中的有效性与安全性：一项随机、活性对照、双盲、III期研究的52周结果
Papp, Kim A.; Jaworski, Janusz; Kwiek, Bartlomiej; Trefler, Jakub; Dudek, Anna; Szepietowski, Jacek C.; Reznichenko, Nataliya; Narbutt, Joanna; Baran, Wojciech; Kolinek, Joanna; Daniluk, Stefan; Bartnicka-Maslowska, Katarzyna; Reich, Adam; Andrashko, Yuriy; Kim, Sunghyun; Bae, Yunju; Jeon, Dabee; Jung, Jinsun; Lee, Hyunseung; Ko, Woori; Kim, Yejin; Thaci, Diamant 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}